Sechenov School
Home › Microbiology › Helicobacter Pylori

Helicobacter pylori

*Helicobacter*

For medical students3 min readUpdated 2026-10-10

Helicobacteriosis is a chronic infection affecting the mucosa of the stomach and duodenum. The causative agent causes persistent inflammation that leads to ulcer formation and the development of neoplastic processes.

ShapeSpiral in tissues, rod-shaped on culture media
Primary TargetGastric and duodenal mucosa
Key EnzymeUrease (constitutes up to 15% of total cellular protein)
Recognition2005 Nobel Prize for discovering the microbe's role in disease

Discovery History and Taxonomy

The genus Helicobacter belongs to the family Helicobacteriaceae. The etymology of the name derives from the Greek word helios, meaning "sun." These microorganisms were first observed in the gastric mucosa by G. Bizzozero in 1893. However, isolating them into an independent genus was achieved much later—in 1983 by researchers B.J. Marshall and J.R. Warren.

Initially, the bacteria were given the acronym CLO (Campylobacter-like organisms) because they closely resembled campylobacters morphologically. The genus received its final name in 1989. The scientific community highly praised this work: in 2005, Marshall and Warren were awarded the Nobel Prize for discovering the role of this microbe in physiology and medicine. To date, more than 20 Helicobacter species have been described, but H. pylori holds the greatest clinical significance for human pathology.

Morphological and Tinctorial Properties

Helicobacters are small microorganisms measuring 2–5 × 0.5–1 µm and do not form spores. Their most important feature is marked polymorphism, meaning the ability to change shape depending on environmental conditions:

Microbes are actively motile. They use lophotrichous flagellation—a tuft of 2–6 flagella located at one pole of the cell—for movement.

Physiology, Cultivation, and Biochemistry

Regarding respiration, Helicobacter is a microaerophile (requiring reduced oxygen levels of 3–15%) and a capnophile (requiring elevated carbon dioxide levels of 10–15%). The optimum temperature for growth is $37^{\circ}C$.

The microorganism is extremely fastidious regarding nutrient media. It cannot utilize high-molecular-weight compounds, so complex media must contain additives: whole blood or serum, activated charcoal, soluble starch, and low-molecular-weight protein hydrolysates. Additionally, the bacterium strictly depends on specific amino acids: arginine, leucine, valine, serine, and phenylalanine.

Its biochemical profile has unique features. Saccharolytic activity is entirely absent—the bacterium does not ferment sugars, utilizing tricarboxylic acids as an energy source. Meanwhile, the bacterium produces several enzymes: catalase, oxidase, alcohol dehydrogenase, and lipases.

Urease and Other Pathogenicity Factors

A complex of virulence factors ensures bacterial survival in the acidic gastric environment, mucosal colonization, and tissue damage. The key enzyme, major species marker, and infection indicator is urease. It is a multi-subunit, metalloenzyme with the highest activity among all bacterial ureases (accounting for up to 15% of total cellular protein).

Role of urease in pathogenesis:

  1. Protection: Creates an ammonia "cloud" around the bacterium, neutralizing hydrochloric acid and raising the pH.
  2. Regulation: If the environment becomes excessively alkaline, the microbe activates oxidases to re-acidify it.
  3. Damage: Ammonium ions cause lysis of epithelial cells and disrupt intercellular junctions.
  4. Inflammation: The enzyme acts as a chemoattractant, recruiting leukocytes and stimulating their pro-inflammatory activation.

In addition to urease, aggression is driven by phospholipase A (destroys cell membranes), adhesins (mediate epithelial attachment), and endotoxin (cell wall lipopolysaccharide).

Specific Toxins and Genetics

Helicobacter exhibits high genetic diversity. Within the host, continuous selection occurs for strains most tropically suited to specific tissues, and adaptation is driven by mutations.

Two specific toxins, which are also associated with bacterial resistance to the antibiotic clarithromycin, are of particular importance:

Mnemonic

To remember Helicobacter's respiratory needs, use the phrase: "Low Oxygen — Microaerophile, High Carbon dioxide — Capnophile."

Frequently asked questions

What aggressive and protective enzymes does Helicobacter pylori produce?

Helicobacter pylori produces enzymes involved in surviving the acidic gastric environment and causing tissue damage.

  • Urease — neutralizes hydrochloric acid via ammonia, causes lysis of epithelial cells, and triggers inflammation.
  • Oxidase — participates in re-acidifying the environment when alkalinization becomes excessive.
  • Phospholipase A — disrupts membranes.
  • Catalase and alcohol dehydrogenase — also produced by H. pylori.
What pathogenicity factors mediate Helicobacter adhesion to the gastric epithelium?

Adhesion of Helicobacter pylori to the gastric epithelium is mediated by adhesins, which facilitate bacterial attachment to epithelial cells.

Which gastrointestinal diseases are associated with Helicobacter pylori infection?

Diseases associated with Helicobacter pylori infection include:

  • Chronic Helicobacter-associated gastritis, including type B bacterial gastritis.
  • Atrophic gastritis.
  • Peptic ulcer disease of the stomach and duodenum.
  • Gastric cancer, including invasive intestinal-type adenocarcinoma developing via the Correa cascade.
  • Gastric MALT lymphoma.
What laboratory diagnostic methods are used to detect Helicobacter pylori?

Methods used to detect Helicobacter pylori include:

  • Histological examination of gastric mucosal biopsies.
  • Rapid urease test (CLO test).
  • 13C-urea breath test.
  • Stool antigen test for H. pylori.
Which antibacterial drugs are included in standard Helicobacter pylori eradication regimens?

First-line Helicobacter pylori eradication regimens include:

  • Clarithromycin — used in standard triple and sequential therapy.
  • Amoxicillin — used in standard triple, high-dose triple, and sequential therapy.
  • Metronidazole — used in quadruple and sequential therapy.
  • Tetracycline — used in classical bismuth-containing quadruple therapy.

These drugs are combined with a proton pump inhibitor; bismuth preparations are also included in certain regimens.

Why doesn't Helicobacter die in the acidic environment of the stomach?

The bacterium produces the enzyme urease, which hydrolyzes urea to release ammonia. Ammonia neutralizes hydrochloric acid and creates a protective alkaline cloud around the microbe.

What shape does the causative agent have?

Helicobacter displays polymorphism. In the human body, it is spiral or S-shaped; on nutrient media, it becomes rod-shaped; and under stress, it converts into a coccoid form.

Does Helicobacter ferment sugars?

No, saccharolytic activity is completely absent. Tricarboxylic acids serve as the exclusive energy source for the bacterium.

Go deeper

More topics in Microbiology

Phagocytosis and the Macrophage SystemImmunomodulatorsEnzyme-Linked Immunosorbent Assay (ELISA)Neisseria gonorrhoeae (Gonococcus)BurkholderiaBifidobacteriaHerpes Simplex VirusMolecular-Genetic Period in MicrobiologyDysbacteriosisAnti-Protozoan and Anti-Helminthic ImmunityHighly Dangerous and Quarantine InfectionsMicrobiology Laboratory OrganizationMicrobiology →